Verdict: Side-by-side breakdown using the Bull Rankings model. HSIC scored 52.7, COR scored 62.1 — COR leads.
Compare another set
HSIC
Henry Schein, Inc.
Medical Distribution · Quality-Growth
52.7
$84.01 · $9.4B
fundamentals as of
Score gap
9.4
COR leads
COR
Cencora, Inc.
Medical Distribution · Quality-Growth
62.1
$323.85 · $61.8B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
CheapestCOR24.0x
Fastest growthCOR+9.3%
Strongest balance sheetHSIC0.81
Highest qualityCOR69 / 100
Largest discount to fair valueCOR-41%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
HSIC
stronger →← stronger
COR
63
Qualityreturns · margins · balance sheet
69
61
Growthrevenue & earnings expansion
73
38
Valuevaluation vs sector peers
48
COR is stronger on 3 of 3 pillars.
Fundamentals, head-to-head
HSIC
COR
$569mC+
FCF
$4.1bB
+6.5%C+
Rev
+9.3%B
0.81C+
D/E
4.47D
24.5xB
P/E
24.0xB+
1.69C+
PEG
0.67A-
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
HSIC
COR
9% below
Price vs fair valuelower is cheaper
41% below
~3%/yr
Growth the price impliesyr-1 FCF growth, fading to 4% · lower = less priced in
~-5%/yr
+5%
1-yr DCF upside
+55%
+9%
5-yr DCF upside
+70%
+15%
10-yr DCF upside
+95%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
HSIC
Why this score
Buying back stock
COR
Why this score
Raising its dividend
Durable high returns
The companies
HSICHenry Schein, Inc.
Medical Distribution · $84.01 · beta 0.84
Why now
Medical Distribution · market cap $9.4b. 9% off the 52-week high of $92.18. 15 sell-side analysts rate this a Buy with a mean 1-yr target of $97.27 (implying +16% upside).
Moat
ROE 13% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. FCF converts 141% of net income — earnings translate cleanly into cash.
Risk
Net margin 3.0% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
CORCencora, Inc.
Medical Distribution · $323.85 · beta 0.58
Why now
Medical Distribution · market cap $61.8b. 14% off the 52-week high of $377.54. PEG 0.67 — paying under fair value for the growth rate. 12 sell-side analysts rate this a Buy with a mean 1-yr target of $369.92 (implying +14% upside).
Moat
ROE 97% — top-decile capital efficiency. Either pricing leverage, low capital intensity, or aggressive buybacks; the durability story depends on which. FCF converts 155% of net income — earnings translate cleanly into cash. $61.8b market cap gives the company enough scale to absorb fixed costs that subscale competitors can't, without yet being so large that growth has to come from acquisition.
Risk
D/E 4.47 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Net margin 0.8% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where HSIC and COR diverge
On the headline score the gap is 9.4 points in favor of COR. The widest single difference is Growth, where COR leads by 11.5 points.
GrowthHSIC 61.3 · COR 72.8COR +11.5
ValueHSIC 38.2 · COR 47.8COR +9.6
QualityHSIC 62.6 · COR 68.7COR +6.1
Pillars run 0–100. Value is judged against each company's own sector, so a Value score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.
Common questions
Is COR or HSIC the better stock?
COR scores higher: COR 62.1, HSIC 52.7 out of 100 on the Bull Rankings quality-growth score, which blends business quality, growth and valuation into one number. A higher score means a stronger business at a more reasonable price — it is not a price target or a recommendation.
Where do COR and HSIC differ most?
The widest gap is growth, where COR leads by 12 points on the 0–100 pillar scale. COR leads all three pillars, so the gap is broad rather than a single-measure difference.
How are COR and HSIC scored?
Each carries the same 0–100 quality-growth score used everywhere on the site, built from three pillars — quality (profitability and returns on capital), growth (revenue and earnings), and value (what you pay for them) — combined as a geometric mean, so a weak pillar cannot be papered over by a strong one.
How current is this comparison?
The whole universe is re-scored every trading day after the US market close, so the scores and fundamentals here reflect the latest published edition.